Gavin Preston

725 total citations
10 papers, 72 citations indexed

About

Gavin Preston is a scholar working on Genetics, Pathology and Forensic Medicine and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Gavin Preston has authored 10 papers receiving a total of 72 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Genetics, 4 papers in Pathology and Forensic Medicine and 3 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Gavin Preston's work include Chronic Lymphocytic Leukemia Research (5 papers), Acute Lymphoblastic Leukemia research (3 papers) and Lymphoma Diagnosis and Treatment (3 papers). Gavin Preston is often cited by papers focused on Chronic Lymphocytic Leukemia Research (5 papers), Acute Lymphoblastic Leukemia research (3 papers) and Lymphoma Diagnosis and Treatment (3 papers). Gavin Preston collaborates with scholars based in United Kingdom and United States. Gavin Preston's co-authors include Julius Merry, Toby A. Eyre, Pam McKay, Matthew R. Wilson, Thomas Creasey, Kim Linton, Fiona Miall, Nimish Shah, Nicolás Martínez‐Calle and Matthew J. Ahearne and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Gavin Preston

8 papers receiving 68 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gavin Preston United Kingdom 5 36 28 26 17 14 10 72
G. Barosi Italy 6 37 1.0× 50 1.8× 18 0.7× 23 1.4× 41 2.9× 11 101
Evridiki Michalis Greece 4 36 1.0× 24 0.9× 17 0.7× 30 1.8× 31 2.2× 7 84
Megan Grosso United States 4 85 2.4× 11 0.4× 18 0.7× 31 1.8× 19 1.4× 5 107
Thomas Creasey United Kingdom 5 38 1.1× 24 0.9× 26 1.0× 20 1.2× 23 1.6× 10 75
G.K. Bascom United States 2 41 1.1× 16 0.6× 7 0.3× 27 1.6× 9 0.6× 2 63
Will Donnellan United States 4 46 1.3× 14 0.5× 11 0.4× 37 2.2× 19 1.4× 6 73
Pegah Farrokhi Iran 4 40 1.1× 27 1.0× 9 0.3× 22 1.3× 7 0.5× 6 63
Sandra Le Guyader-Peyrou France 3 56 1.6× 33 1.2× 10 0.4× 40 2.4× 9 0.6× 6 78
Magda Alexis France 4 33 0.9× 15 0.5× 6 0.2× 36 2.1× 18 1.3× 9 57
Lauren E. Strelec United States 5 68 1.9× 30 1.1× 21 0.8× 47 2.8× 7 0.5× 11 81

Countries citing papers authored by Gavin Preston

Since Specialization
Citations

This map shows the geographic impact of Gavin Preston's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gavin Preston with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gavin Preston more than expected).

Fields of papers citing papers by Gavin Preston

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gavin Preston. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gavin Preston. The network helps show where Gavin Preston may publish in the future.

Co-authorship network of co-authors of Gavin Preston

This figure shows the co-authorship network connecting the top 25 collaborators of Gavin Preston. A scholar is included among the top collaborators of Gavin Preston based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gavin Preston. Gavin Preston is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Figueroa, Rocío, Alexandros Rampotas, Daniel M. Halperin, et al.. (2023). Venetoclax ramp‐up strategies for chronic lymphocytic leukaemia in the United Kingdom: a real world multicentre retrospective study. British Journal of Haematology. 202(1). 48–53. 6 indexed citations
2.
Preston, Gavin, et al.. (2022). Small Lymphocytic Lymphoma Masquerading as a Vallecular Mucous Retention Cyst. SHILAP Revista de lepidopterología. 18(4). 298–301.
3.
Kuo, Chris RuiWen, et al.. (2022). Nodules, nodes and non-functioning macrophages: A risk with ibrutinib therapy. The Journal of the Royal College of Physicians of Edinburgh. 52(1). 46–47.
4.
5.
Wilson, Matthew R., Toby A. Eyre, Nicolás Martínez‐Calle, et al.. (2020). Timing of high-dose methotrexate CNS prophylaxis in DLBCL: an analysis of toxicity and impact on R-CHOP delivery. Blood Advances. 4(15). 3586–3593. 32 indexed citations
6.
Thein, Kyaw Zin, et al.. (2020). Efficacy of daratumumab combination regimen in patients with multiple myeloma: A combined analysis of phase III randomized controlled trials. SHILAP Revista de lepidopterología. 1(1). 262–266. 4 indexed citations
7.
8.
Preston, Gavin, Christopher B. Jones, John Sarantopoulos, et al.. (2006). Phase I study of the effects of hepatic impairment on the pharmacokinetic (PK) and safety of satraplatin in patients with refractory non-hematologic cancer. Journal of Clinical Oncology. 24(18_suppl). 2045–2045. 2 indexed citations
9.
Mays, Theresa A., John Sarantopoulos, Anthony W. Tolcher, et al.. (2006). MDX-070, a human anti-plasma antibody, administered as either a single dose or as multiple doses to patients with hormone-refractory prostate cancer. Journal of Clinical Oncology. 24(18_suppl). 14549–14549. 3 indexed citations
10.
Merry, Julius & Gavin Preston. (1963). The effect of buffered lobeline sulphate on cigarette smoking.. PubMed. 190. 628–31. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by G. Barosi Breakdown of academic impact, for papers by Evridiki Michalis Breakdown of academic impact, for papers by Megan Grosso Breakdown of academic impact, for papers by Thomas Creasey Breakdown of academic impact, for papers by G.K. Bascom Breakdown of academic impact, for papers by Will Donnellan Breakdown of academic impact, for papers by Pegah Farrokhi Breakdown of academic impact, for papers by Sandra Le Guyader-Peyrou Breakdown of academic impact, for papers by Magda Alexis Breakdown of academic impact, for papers by Lauren E. Strelec
Rankless by CCL
2026